Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00176995 · ClinicalTrials.gov registry record · Phase 2
Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae
A Phase 2 study, sponsored by Hordinsky, Maria K., MD.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT00176995: Completed Phase 2 study, sponsored by Hordinsky, Maria K., MD.
NCT00176995 is a Phase 2 study that has completed, run by Hordinsky, Maria K., MD. The registered enrollment target is 15 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00176995, a Phase 2 study, has completed, sponsored by Hordinsky, Maria K., MD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
This trial is designed to gain insight into the mechanism of action of eflornithine hydrochloride in men and to aid in determining if this compound is deserving of further development for a pseudofolliculitis barbae indication. This study will also provide knowledge which will be useful in designing future PFB trials in this indication is pursued.
Interventions
- DRUG 15% Eflornithine Hdyrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 1999-03 |
| Est. Completion | 2000-10 |
| Phase | Phase 2 |
What the finished NCT00176995 record still lists
NCT00176995 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which 15% Eflornithine Hdyrochloride is the first listed.
NCT00176995 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00176995 about?
NCT00176995 is a clinical study titled "Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae". This trial is designed to gain insight into the mechanism of action of eflornithine hydrochloride in men and to aid in determining if this compound is deserving of further development for a pseudofolliculitis barbae indication. This study will also provide knowledge which will be useful in designing...
What is the current status of trial NCT00176995?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 1999-03. Estimated completion is 2000-10.
What interventions are being tested in trial NCT00176995?
The interventions under investigation include: 15% Eflornithine Hdyrochloride (DRUG).
Who is sponsoring clinical trial NCT00176995?
This trial is sponsored by Hordinsky, Maria K., MD, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00176995's enrollment target sits among peer trials
15 1919th of 2000 higher than 60 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia